Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
Borchmann P, Haverkamp H, Diehl V, Cerny T, Markova J, Ho AD, Eich HT, Mueller-Hermelink HK, Kanz L, Greil R, Rank A, Paulus U, Smardova L, Huber C, Dörken B, Nerl C, Krause SW, Mueller RP, Fuchs M, Engert A. Borchmann P, et al. Among authors: cerny t. J Clin Oncol. 2011 Nov 10;29(32):4234-42. doi: 10.1200/JCO.2010.33.9549. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990399 Clinical Trial.
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L, Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M, Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A, Hasford J, Hehlmann R, Saußele S; German Chronic Myeloid Leukemia Study Group; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK). Proetel U, et al. Ann Hematol. 2014 Jul;93(7):1167-76. doi: 10.1007/s00277-014-2041-0. Ann Hematol. 2014. PMID: 24658964 Free PMC article. Clinical Trial.
[Intravitreal chemotherapy for intraocular lymphoma].
Helbig H, Cerny T, de Smet MD. Helbig H, et al. Among authors: cerny t. Ophthalmologe. 2003 Feb;100(2):145-9. doi: 10.1007/s00347-002-0692-z. Ophthalmologe. 2003. PMID: 12589460 German.
Pleura mesothelioma: combined modality treatments.
Cerny T, Giaccone G. Cerny T, et al. Ann Oncol. 2002;13 Suppl 4:217-25. doi: 10.1093/annonc/mdf663. Ann Oncol. 2002. PMID: 12401694 Free article. Review. No abstract available.
[New treatments of malignant lymphoma--a review].
Mark M, Cerny T. Mark M, et al. Among authors: cerny t. Ther Umsch. 2010 Oct;67(10):537-43. doi: 10.1024/0040-5930/a000090. Ther Umsch. 2010. PMID: 20886460 Review. German.
Mechanism of action of rituximab.
Cerny T, Borisch B, Introna M, Johnson P, Rose AL. Cerny T, et al. Anticancer Drugs. 2002 Nov;13 Suppl 2:S3-10. doi: 10.1097/00001813-200211002-00002. Anticancer Drugs. 2002. PMID: 12710585 Review.
252 results